Publicaciones (314) Publicaciones de MARTA EUGENIA ALARCON RIQUELME

2024

  1. A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

    Scientific reports, Vol. 14, Núm. 1, pp. 3000

  2. Approaching Mass Cytometry Translational Studies by Experimental and Data Curation Settings

    Methods in Molecular Biology (Humana Press Inc.), pp. 369-394

  3. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis

    Kidney International Reports

  4. Local Ancestry at the Major Histocompatibility Complex Region is Not a Major Contributor to Disease Heterogeneity in a Multiethnic Lupus Cohort

    Arthritis and Rheumatology, Vol. 76, Núm. 4, pp. 614-619

  5. Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

    Annals of the Rheumatic Diseases

  6. Response to the letter 'testing the effectiveness of MyPROSLE in classifying patients with lupus nephritis'

    Briefings in Bioinformatics

  7. Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs)

    Joint Bone Spine

2023

  1. A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren’s Syndrome

    Clinical Reviews in Allergy and Immunology, Vol. 64, Núm. 3, pp. 392-411

  2. A basket genetic trial of the vasculitides

    Nature Reviews Rheumatology

  3. Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation

    Arthritis and Rheumatology

  4. Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (Nature Communications, (2022), 13, 1, (4287), 10.1038/s41467-022-30773-y)

    Nature Communications

  5. Corrigendum to ‘Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus’ [J. Autoimmun. 136 (April 2023) 103025] (Journal of Autoimmunity (2023) 136, (S0896841123000343), (10.1016/j.jaut.2023.103025))

    Journal of Autoimmunity

  6. Differential diagnosis of systemic lupus erythematosus and Sjögren's syndrome using machine learning and multi-omics data

    Computers in Biology and Medicine, Vol. 152

  7. Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus

    Journal of Autoimmunity, Vol. 136

  8. Down-Regulation–Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon-γ Production

    Arthritis and Rheumatology, Vol. 75, Núm. 6, pp. 961-972

  9. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  10. Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH

    Diabetologia, Vol. 66, Núm. 7, pp. 1260-1272

  11. Gut epithelial barrier dysfunction in lupus triggers a differential humoral response against gut commensals

    Frontiers in Immunology, Vol. 14

  12. Lack of strong innate immune reactivity renders macrophages alone unable to control productive Varicella-Zoster Virus infection in an isogenic human iPSC-derived neuronal co-culture model

    Frontiers in Immunology, Vol. 14

  13. Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus

    Frontiers in Immunology, Vol. 14